Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
N
Shared by NobleBlocks on Jul 1, 2017 • 12:00 AM UTC
Authors:
Stanley B Cohen
,
Yoshiya Tanaka
,
Xavier Mariette
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials | NobleBlocks
